Anwesh Kamireddy

Statistics

Publications

Citations

745

H-Index

Active since

2013

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Salk Institute for Biological Studies

Anwesh Kamireddy is an author at Genomics Institute of the Novartis Research Foundation specializing in diabetes mellitus, cell signaling, and pharmacology.

Publications per year

2013–2020

Publications

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation

Weijun Shen, Brandon L. Taylor, Qihui Jin et al. · Nature Communications · 2015 · 201 citations · Full text

Medicine, Endocrinology, Pharmacology +17

AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes

Nathan P. Young, Anwesh Kamireddy, Jeanine L. Van Nostrand et al. · Genes & Development · 2016 · 187 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +17

The AMPK-Related Kinases SIK1 and SIK3 Mediate Key Tumor-Suppressive Effects of LKB1 in NSCLC

Pablo E. Hollstein, Lillian J. Eichner, Sonja N. Brun et al. · Cancer Discovery · 2019 · 165 citations · Full text

Medicine, Molecular Biology, Oncology +14

Small-Molecule Inducer of β Cell Proliferation Identified by High-Throughput Screening

Weijun Shen, Matthew S. Tremblay, V. Deshmukh et al. · Journal of the American Chemical Society · 2013 · 98 citations

Life Sciences, Cell Biology, Molecular Biology +17

Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133

Yahu A. Liu, Qihui Jin, Yefen Zou et al. · Journal of Medicinal Chemistry · 2020 · 77 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–5 of 6